Aptar Pharma, a global provider in drug delivery systems and active material science solutions, is showcasing its portfolio of drug delivery services and solutions.
 
At Booth 2K40, Hall 2, Aptar Pharma will present its newest products across nasal, pulmonary, eye care, injectables and dermal drug delivery routes, as well as its digital health and active material science solutions.
 
Aptar Pharma will introduce Advaspray Unidose Liquid Nasal Spray, designed for reliable and accurate nasal delivery for acute and life-saving treatments.
 
The company will also highlight expanded capacity and capabilities, including its Global Injectables Expansion Program for increasing capacity in France, the U.S. and China.
 
Aptar Digital Health will highlight its offering for personalized digital support to help improve treatment experience, including the iPUMP, designed for patients undergoing allergen immunotherapy treatments (AIT) to address challenges such as non-adherence to AIT therapy, premature discontinuation, and ease of use of treatment.
 
Aptar CSP Technologies will showcase N-Sorb to help address new concerns related to N-nitrosamine impurities. Leveraging their proven Activ-Blister platform, N-Sorb is engineered to mitigate nitrosamine formation within the headspace of the drug product.
 
Session 
Aptar Pharma will be presenting a Product Innovation Session at CPHI Barcelona entitled, Mission Possible – Sustainability in Pharmaceutical Primary Packaging. Presented by Dr. Stefan Hellbardt, Vice President Business Development and Scientific Affairs, and Julien Storz, Director of Business Development, Aptar Pharma Consumer Health Care. Tuesday, October 24, Room 4.2, Conference Centre 4, from 3:30 p.m. to 3:55 p.m.